OCULAR THERAPEUTIX

ocular-therapeutix-logo

Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.

#SimilarOrganizations #People #Financial #Event #Website #More

OCULAR THERAPEUTIX

Social Links:

Industry:
Biotechnology Health Care Medical Device

Founded:
2006-01-01

Address:
Bedford, Massachusetts, United States

Country:
United States

Website Url:
http://www.ocutx.com

Total Employee:
51+

Status:
Active

Contact:
(781)357-4000

Email Addresses:
[email protected]

Total Funding:
271.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics


Similar Organizations

injectsense-logo

Injectsense

Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.


Current Advisors List

tara-butler_image

Tara Butler Board of Directors @ Ocular Therapeutix
Board_member

alan-crane_image

Alan Crane Board Member @ Ocular Therapeutix
Board_member

Current Employees Featured

karen-leigh-edwards_image

Karen-Leigh Edwards
Karen-Leigh Edwards Senior Vice President of Technical Operations @ Ocular Therapeutix
Senior Vice President of Technical Operations
2021-09-01

daniel-m-bollag_image

Daniel M. Bollag
Daniel M. Bollag Chief Strategy Officer @ Ocular Therapeutix
Chief Strategy Officer

michael-goldstein_image

Michael Goldstein
Michael Goldstein Chief Medical Officer @ Ocular Therapeutix
Chief Medical Officer

antony-mattessich_image

Antony Mattessich
Antony Mattessich President and Chief Executive Officer @ Ocular Therapeutix
President and Chief Executive Officer

donald-notman_image

Donald Notman
Donald Notman Chief Financial Officer @ Ocular Therapeutix
Chief Financial Officer

farhad-khosravi_image

Farhad Khosravi
Farhad Khosravi Co - Founder, Director & Chairman @ Ocular Therapeutix
Co - Founder, Director & Chairman

peter-jarrett_image

Peter Jarrett
Peter Jarrett Chief Scientific Officer @ Ocular Therapeutix
Chief Scientific Officer

Founder


amarpreet-sawhney_image

Amarpreet Sawhney

farhad-khosravi_image

Farhad Khosravi

Stock Details


Company's stock symbol is NASDAQ:OCUL

Investors List

sparta-group_image

Sparta Group

Sparta Group investment in Series D - Ocular Therapeutix

dan-burgess_image

Dan Burgess

Dan Burgess investment in Series D - Ocular Therapeutix

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series D - Ocular Therapeutix

ascension-ventures_image

Ascension Ventures

Ascension Ventures investment in Series D - Ocular Therapeutix

polaris-venture-capital_image

Polaris Venture Capital

Polaris Venture Capital investment in Series D - Ocular Therapeutix

baxter-international_image

Baxter International

Baxter International investment in Series D - Ocular Therapeutix

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series D - Ocular Therapeutix

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series D - Ocular Therapeutix

ascension-ventures_image

Ascension Ventures

Ascension Ventures investment in Series D - Ocular Therapeutix

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series D - Ocular Therapeutix

Official Site Inspections

http://www.ocutx.com Semrush global rank: 275.99 K Semrush visits lastest month: 240.75 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ocular Therapeutix" on Search Engine